跳至主要内容
临床试验/NCT05600179
NCT05600179已完成不适用

Evaluation of Changes in Epivascular Glia Before and After Intravitreal Dexamethasone Implant : an OCT Pilot Study

Federico II University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2021年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
38
试验地点
1
主要终点
Changes in epivascular glia after Dexamethasone implant in patients with diabetic retinopathy and inflammatory macular edema

研究概览

简要总结

The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •diabetic retinopathy complicated by macular edema

排除标准

  • •congenital eye disorders,
  • •previous diagnosis of other ocular diseases
  • •history of vitreous hemorrhage

研究组 & 干预措施

patients with diabetic macular edema

干预措施: Dexamethasone intravitreal implant (Drug)

结局指标

主要结局

Changes in epivascular glia after Dexamethasone implant in patients with diabetic retinopathy and inflammatory macular edema

时间窗: up to 6 months

次要结局

未报告次要终点

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gilda Cennamo

professor

Federico II University

研究点 (1)

Loading locations...

相似试验